Irish neurologist urges HSE to fund Alzheimer's drug access

A consultant neurologist at Tallaght University Hospital publicly called on Ireland's Health Service Executive (HSE) to provide access to a drug that slows Alzheimer's progression. The request signals potential pressure on the HSE to expedite reimbursement decisions, but no specific drug or timeline was named. This is a domestic health-policy development with no immediate market impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works